Organisation paid for research Program year 2025 Source: CMS Open Payments

Verus Clinical Research Corp

Neither a doctor nor a teaching hospital

Research payments

$4,175,410

1,250 payments

Through program year 2025, Verus Clinical Research Corp is reported as receiving $4,175,410 in research payments, across 1,250 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2025	Research	$3,375,896	997
2024	Research	$799,514	253

Breakdown

Who paid Research payments · program years 2024–2025

ACADIA Pharmaceuticals Inc $3,845,706 946 payments
Incyte Corporation $329,704 304 payments

Studies the money was for Research payments · program years 2024–2025

Acp-204-008 $2,055,234 648 payments
Acp-204-006 $1,790,472 298 payments
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Povorcitinib in Participants with Inadequately Controlled Moderate-to-Severe Asthma $273,100 150 payments
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Povorcitinib in Participants with Inadequately Controlled Moderate-to-Severe Asthma $56,604 154 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.